SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-134399
Filing Date
2016-11-14
Accepted
2016-11-14 17:41:15
Documents
42
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v451900_10q.htm 10-Q 519222
2 EXHIBIT 31.1 v451900_ex31-1.htm EX-31.1 11146
3 EXHIBIT 31.2 v451900_ex31-2.htm EX-31.2 11117
4 EXHIBIT 32.1 v451900_ex32-1.htm EX-32.1 4947
5 EXHIBIT 32.2 v451900_ex32-2.htm EX-32.2 4249
  Complete submission text file 0001144204-16-134399.txt   2675120

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ck0001651407-20160930.xml EX-101.INS 395235
7 XBRL TAXONOMY EXTENSION SCHEMA ck0001651407-20160930.xsd EX-101.SCH 28481
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ck0001651407-20160930_cal.xml EX-101.CAL 20126
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ck0001651407-20160930_def.xml EX-101.DEF 190095
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ck0001651407-20160930_lab.xml EX-101.LAB 201291
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ck0001651407-20160930_pre.xml EX-101.PRE 217946
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 212-554-4366
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55506 | Film No.: 161996525
SIC: 2834 Pharmaceutical Preparations